| Identification of novel noninvasive diagnostics biomarkers in the Parkinson’s diseases and improving the disease classification using support vector machine S Moradi, L Tapak, S Afshar BioMed Research International 2022 (1), 5009892, 2022 | 21 | 2022 |
| Role of microbiota short-chain fatty acid chains in the pathogenesis of autoimmune diseases A Rasouli-Saravani, K Jahankhani, S Moradi, M Gorgani, Z Shafaghat, ... Biomedicine & Pharmacotherapy 162, 114620, 2023 | 15 | 2023 |
| Cinnamic acid derivatives as potential matrix metalloproteinase-9 inhibitors: molecular docking and dynamics simulations MH Malekipour, F Shirani, S Moradi, A Taherkhani Genomics & Informatics 21 (1), 2023 | 4 | 2023 |
| BACE1 Inhibition Utilizing Organic Compounds Holds Promise as a Potential Treatment for Alzheimer’s and Parkinson’s Diseases R Amini, S Moradi, R Najafi, M Mazdeh, A Taherkhani Oxidative Medicine and Cellular Longevity 2024 (1), 6654606, 2024 | 1 | 2024 |
| An inclusive study on cytokine gene expression in Parkinson's disease: Advanced analysis using Bayesian regression model S Moradi, A Zamani, M Mazdeh, M Ramezani, A Komaki, E Talebi-Ghane, ... Human Immunology 84 (2), 123-129, 2023 | 1 | 2023 |
| Different Gene Expression Patterns of IL-1 Family Members in Parkinson's Disease: Results from Bayesian Regression Model N Jafariaghdam, M Khoshmirsafa, A Zamani, E Talebi-Ghane, S Moradi, ... Iranian Journal of Allergy, Asthma and Immunology, 1-13, 2024 | | 2024 |
| MiR-15b and let-7a as Non-invasive Diagnostic Biomarkers of Alzheimer’s Disease Using an Artificial Neural Network MD Talemi, L Tapak, AR Haghi, P Ahghari, S Moradi, S Afshar | | 2023 |
| Structure-Based Virtual Screening of Cinnamic Acid Analogs Against RIPK3: Implications for Anti-Inflammatory Drug Discovery E Khoshbin, SMS Rahmani-Abidar, S Moradi, A Taherkhani, ... | | 2023 |
